Browse Data and Analysis

In 2020, China committed to a number of reforms to its agricultural biotechnology policies under the U.S.-China Economic and Trade Agreement (“Phase One Agreement”).

In 2019, there have been no revisions or amendments to China’s regulatory approval process for agriculture biotechnology.